| Q58000942 | A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome |
| Q52615711 | Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. |
| Q43043063 | Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis |
| Q45924363 | Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. |
| Q51025698 | Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. |
| Q46585922 | Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome |
| Q33595764 | Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia |
| Q37216310 | Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia |
| Q42504372 | Diffuse large B-cell lymphoma genotyping on the liquid biopsy |
| Q52621343 | Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. |
| Q46719544 | Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders |
| Q37697850 | Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness |
| Q51548976 | Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. |
| Q54538115 | High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia. |
| Q28394721 | Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia |
| Q46755084 | MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia |
| Q58001001 | Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study |
| Q52614373 | Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis. |
| Q27851685 | Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia |
| Q58001002 | Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome |
| Q36193517 | The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development |
| Q51609722 | The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. |
| Q37243257 | The genetics of nodal marginal zone lymphoma |
| Q46490525 | The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors |
| Q52591762 | The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. |